A Real World Study of Participants With Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor Mutation (EGFRm)
Clinical trial NCT07680907 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07680907
- Sponsor
- Janssen-Cilag Farmaceutica Ltda.
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-09-30
- Primary completion
- 2026-11-30
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.